Quick Answer
RxSight, Inc. reported Operating Income of -$48.19 million for fiscal year 2025.
RxSight, Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$48.19M | -30.7% |
| 2024 | -$36.86M | +26.4% |
| 2023 | -$50.09M | +20.9% |
| 2022 | -$63.32M | -19.9% |
| 2021 | -$52.79M | -49.1% |
| 2020 | -$35.41M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$12.18M | -32.0% | +13.0% |
| June 30, 2025 | -$14.00M | -68.0% | -31.2% |
| March 31, 2025 | -$10.67M | -0.0% | -15.7% |
| September 30, 2024 | -$9.23M | +26.3% | -10.7% |
| June 30, 2024 | -$8.33M | +38.8% | +21.9% |
| March 31, 2024 | -$10.67M | +18.5% | +14.7% |
| September 30, 2023 | -$12.51M | +21.6% | +8.2% |
| June 30, 2023 | -$13.62M | +13.7% | -4.0% |
- RxSight, Inc. showed a decrease of -30.7% in Operating Income compared to the prior fiscal year.
- Over the 2020–2025 period, RxSight, Inc.’s operating income has declined by 36.1% (from -$35.41 million to -$48.19 million).
- The most recent figure is from RxSight, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: